Department of Laboratory Medicine, Med+X Center for Manufacturing, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Anal Chem. 2022 Jun 28;94(25):9122-9129. doi: 10.1021/acs.analchem.2c01530. Epub 2022 Jun 11.
Although there are many interferon gamma (IFN-γ)-based tools for tuberculosis (TB) diagnosis, they are less sensitive and laborious. Here, we developed an IFN-γ aptasensor using pyrophosphate-cerium coordination polymeric nanoparticles (PPi-Ce CPNs) as signal reporters and a double-stranded DNA as a probe. The sensor was realized by sterically regulating the polymerization elongation of terminal deoxynucleotidyl transferase (TdT) and the selective recognition reaction of PPi-Ce CPNs. This method employs PPi-Ce CPNs to selectively identify Cu and polyT-templated copper nanoparticles (Cu NPs), as well as a TdT-assisted amplification technique. Our data showed that under optimized experimental conditions, a limit of detection of as low as 0.25 fg/mL was achieved, with a linear range of 1-100 fg/mL, and a good target protein specificity. The detection sensitivity was an order of magnitude higher than that observed with Cu NPs when used as signal reporters. This IFN-γ quantification technique was further validated in clinical samples using 57 clinical TB patients (22 negative and 35 positive). Our findings agreed with those from enzyme-linked immunosorbent assay, GeneXpert MTB/rifampin assay, and polymerase chain reaction detection of TB-DNA and those from clinical imaging techniques. Therefore, our analytical system may provide an additional and more sensitive tool for the early diagnosis of TB.
虽然有许多基于干扰素γ(IFN-γ)的结核病(TB)诊断工具,但它们的灵敏度和繁琐度都较低。在这里,我们开发了一种使用焦磷酸铈配位聚合物纳米粒子(PPi-Ce CPNs)作为信号报告物和双链 DNA 作为探针的 IFN-γ适体传感器。该传感器通过末端脱氧核苷酸转移酶(TdT)的聚合伸长的空间调节和 PPi-Ce CPNs 的选择性识别反应来实现。该方法利用 PPi-Ce CPNs 选择性识别 Cu 和聚 T 模板铜纳米颗粒(Cu NPs),以及 TdT 辅助的扩增技术。我们的数据表明,在优化的实验条件下,检测限低至 0.25 fg/mL,线性范围为 1-100 fg/mL,具有良好的靶蛋白特异性。与用作信号报告物的 Cu NPs 相比,检测灵敏度提高了一个数量级。该 IFN-γ 定量技术进一步通过 57 例临床 TB 患者(22 例阴性和 35 例阳性)的临床样本进行了验证。我们的发现与酶联免疫吸附测定、GeneXpert MTB/利福平检测、TB-DNA 的聚合酶链反应检测以及临床成像技术的结果一致。因此,我们的分析系统可能为 TB 的早期诊断提供一种额外的、更敏感的工具。